Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21
Phase 32

Trial Status

Completed1
Other2

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT06569108Phase 3Active Not Recruiting
Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors
Hemophilia A Without InhibitorHemophilia B Without Inhibitor
PrincipalinvestigatorStart date: 2024-04-01
NCT06312475Phase 3Active Not Recruiting
Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors
Hemophilia A With InhibitorHemophilia B With Inhibitor
PrincipalinvestigatorStart date: 2024-01-09
NCT05421429Phase 2Completed
KN057 Multiple Dose Study in Moderately Severe to Severe Hemophilia
Hemophilia
PrincipalinvestigatorStart date: 2022-07-07

Research Network

Collaboration Network

30 collaborators·75 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Ziqiang Yu, Doctor

The First Affiliated Hospital of Soochow University

Similar
3 trials

Shared therapeutic areas:

Hemophilia AHemophilia A With InhibitorHemophilia A Without Inhibitor+2 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 3 trials
Similarity Score62%

Renchi Yang, Doctor

Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences

Similar
4 trials

Shared therapeutic areas:

Hemophilia AHemophilia A With InhibitorHemophilia A Without Inhibitor+2 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 3 trials
Similarity Score62%

Jing Sun, Doctor

Nanfang Hospital, Southern Medical University

Similar
3 trials

Shared therapeutic areas:

Hemophilia AHemophilia A With InhibitorHemophilia A Without Inhibitor+2 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 3 trials
Similarity Score62%

Changcheng Zheng, Doctor

The First Affiliated Hospital of China University of Science and Technology (Anhui Provincial)

Similar
4 trials

Shared therapeutic areas:

Hemophilia AHemophilia A With InhibitorHemophilia A Without Inhibitor+2 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 3 trials
Similarity Score62%

Sujun Gao, Doctor

Bethune First Hospital of Jilin University

Moderately Similar
2 trials

Shared therapeutic areas:

Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia B With Inhibitor+1 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 2 trials
Similarity Score48%

Runhui Wu, Doctor

Beijing Children's Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia B With Inhibitor+1 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 2 trials
Similarity Score48%

Wei Yang, Doctor

Shengjing Hospital of China University

Moderately Similar
2 trials

Shared therapeutic areas:

Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia B With Inhibitor+1 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 2 trials
Similarity Score48%

Yanping Song, Doctor

Xi'an Central Hospital

Moderately Similar
3 trials

Shared therapeutic areas:

Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia B With Inhibitor+1 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 2 trials
Similarity Score48%

Yaming Xi, Doctor

LanZhou University

Moderately Similar
2 trials

Shared therapeutic areas:

Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia B With Inhibitor+1 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 2 trials
Similarity Score48%

Jingyu Yan, Doctor

North China University of Science and Technology

Moderately Similar
2 trials

Shared therapeutic areas:

Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia B With Inhibitor+1 more

Worked with same sponsors:

Suzhou Alphamab Co., Ltd.
Collaborated on 2 trials
Similarity Score48%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT06569108Phase 3PrincipalInvestigator

Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B Without Inhibitors

Hemophilia A Without InhibitorHemophilia B Without Inhibitor
Active Not Recruiting
NCT06312475Phase 3PrincipalInvestigator

Efficacy and Safety of KN057 Prophylaxis in Patients With Haemophilia A or B With Inhibitors

Hemophilia A With InhibitorHemophilia B With Inhibitor
Active Not Recruiting
NCT05421429Phase 2PrincipalInvestigator

KN057 Multiple Dose Study in Moderately Severe to Severe Hemophilia

Hemophilia
Completed

All 3 trials loaded